Technology | March 15, 2013

Toshiba’s new offering enhances cardiac function assessment

Toshiba echo activation image showing a color-coded map of where activation starts and ends during each contraction. This example shows a posterior lateral infarction timing defect.

An activation imaging example showing a heart with left bundle branch block. Its believed this type of imaging will help lead to better CRT lead placement optimization.


March 15, 2013 – For better treatment planning during cardiac resynchronization therapy (CRT), Toshiba America Medical System Inc.’s Activation Imaging is the company’s latest addition to its 3-D Wall Motion Tracking software. Activation Imaging is an U.S. Food and Drug Administration (FDA)-cleared, proprietary technology available on the Aplio Artida cardiovascular ultrasound system.

When the heart is not functioning properly, different segments activate at different moments in time. Activation Imaging, in conjunction with Toshiba’s comprehensive 3-D Wall Motion Tracking software, allows clinicians to evaluate dyssynchrony at the onset of the heart’s contraction and to properly identify the left ventricle’s pumping strength and timing for more accurate lead placements in CRT treatment.

“Toshiba continues to pioneer innovative ultrasound technology to improve patient outcomes,” said Tomohiro Hasegawa, director, Ultrasound Business Unit, Toshiba. “Studies show that CRT procedures have a 33 percent failure rate.[1] Activation Imaging’s ability to measure dyssynchrony at a more appropriate moment in time, the onset of contraction, will provide greater confidence during CRT planning to improve patient outcomes and lower healthcare costs.”

Toshiba showcased Activation Imaging at this year’s American College of Cardiology (ACC) annual meeting in San Francisco, March 9 to 11.

For more information: www.medical.toshiba.com

1. Abraham WT, Fisher WG, Smith AL, et al. “MIRACLE Study Group. Multicenter InSync Randomized Clinical Evaluation. Cardiac resynchronization in chronic heart failure.” N Engl J Med 2002;346: 1845–53.


Related Content

News | FDA

July 8, 2025 — Mendaera, Inc., a healthcare technology company focused on developing robotics that can be deployed ...

Time July 08, 2025
arrow
News | Point-of-Care Ultrasound (POCUS)

June 17, 2025 — Royal Philips has announced the global launch of the Flash Ultrasound System 5100 POC — a new point-of ...

Time June 19, 2025
arrow
News | Lung Imaging

June 18, 2025 — Exo recently announced that now included on its Exo Iris is the first ever FDA 510(k) cleared AI for ...

Time June 18, 2025
arrow
News | Artificial Intelligence

April 16, 2025 — An artificial intelligence (AI) program trained to review images from a common medical test can detect ...

Time April 16, 2025
arrow
News | Ultrasound Women's Health

April 11, 2025 — Contrast-enhanced ultrasound (CEUS) is a safe and accurate diagnostic imaging option for pregnant women ...

Time April 11, 2025
arrow
News | Focused Ultrasound Therapy

March 31, 2025 — Neuropathic pain affects up to 10 percent of the global population and can be challenging to manage ...

Time April 02, 2025
arrow
News | Breast Imaging

March 20, 2025 — GE HealthCare has launched Invenia Automated Breast Ultrasound (ABUS) Premium, the latest 3D ultrasound ...

Time March 21, 2025
arrow
News | X-Ray

March 18, 2025 — GE HealthCare recently announced a collaboration with NVIDIA expanding the existing relationship ...

Time March 19, 2025
arrow
News | Breast Imaging

Feb. 26, 2025 — iCAD, Inc. a provider of clinically proven AI-powered cancer detection solutions, and Koios Medical, a ...

Time March 03, 2025
arrow
News | Focused Ultrasound Therapy

Jan. 8, 2025 - EDAP TMS SA, a supplier of robotic energy-based therapies, has announced that the first patient has been ...

Time January 08, 2025
arrow
Subscribe Now